Medical Devices Investors & VC Firms in Hong Kong
13 firms in this list, with a median first check of $3M. 2 of them lead rounds. Generated from verified public data and updated continuously.
HongShan Capital Group
Hong KongSeed–Growth$100K – $50M
89 people
IDG Capital
Hong KongPre-Seed–Late Stage$1M – $100M
8 people
Lilly Asia Ventures
Hong KongPre-Seed–Series C
3 people
LAV
Hong KongSeed–Series C$5M – $15M
3 people
Saltagen Ventures
Hong KongSeed–Series B
20 people
Kinled Holding
Hong KongSeed–Series A
1 person
ORI Capital
Hong KongSeed–Series A
15 people
PacBridge Capital Partners
Hong KongSeed–Growth
5 people
Alibaba Entrepreneurs Fund
Hong KongSeed–Series A
2 people
Hony Capital Ltd.
Hong KongGrowth–Late Stage$6M
6 people
Big Wealth International
Hong KongPre-Seed–Seed
Centurium Capital
XiamenGrowth–Late Stage
3 people
YF Capital
ShanghaiSeries A–Late Stage
4 people
Frequently asked questions
- Who are the top medical devices investors & vc firms in hong kong?
- Top medical devices investors & vc firms in hong kong include HongShan Capital Group, IDG Capital, Lilly Asia Ventures, LAV, Saltagen Ventures, Kinled Holding, ORI Capital, PacBridge Capital Partners — 13 firms in total meet the criteria.
- What is the typical first check among medical devices investors & vc firms in hong kong?
- The median first check among the 13 medical devices investors & vc firms in hong kong tracked here is $3M.
- How many medical devices investors & vc firms in hong kong lead rounds?
- 2 of the 13 medical devices investors & vc firms in hong kong tracked here lead investment rounds.
Related lists
Investors & VC Firms in North America (12941)Investors & VC Firms in United States (11979)Investors & VC Firms in Europe (5859)Investors & VC Firms in Global (4787)AI & Machine Learning Investors & VC Firms (4629)Fintech Investors & VC Firms (4588)SaaS Investors & VC Firms (4239)Healthtech Investors & VC Firms (4227)Enterprise Software Investors & VC Firms (4136)Crypto & Web3 Investors & VC Firms (3986)
Data sourced from public filings and firms' own websites — see our methodology.





















